hotspot -WSS

hotspot

author：explore 2025-09-06 05:03:09 - browse：2683

SAN DIEGO — After starting off the year with lower revenue projections than market analysts had hoped for, San Diego-based genomics giant Illumina lowered expectations again on Wednesday, forecasting annual growth of 1% compared to the previous year.

The market’s response was swift. Minutes after the company issued its press release, shares in Illumina dipped from $184.49 to below $172 during after-hours trading.

In its release, Illumina noted that it expects revenue from the company’s core business to be essentially the same this year compared to last, and that it expects revenue from Grail, the cancer diagnostics company that Illumina acquired for $8 billion in the fall of 2021, to remain in the range of $90 and $100 million.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Doudna institute plans to 'cure hundreds of diseases' with CRISPR

WSS

As JPM 2024 winds down, some health tech firms project optimism

Readout LOUD podcast: 2023 in review, and a look at biotech in 2024

Kale crackers and hibiscus tea: My five days on a 'fasting diet'

Obesity now affects over 1 billion people worldwide, study finds

Pfizer highlights cancer drugs it thinks could reignite investor interest

DeSantis can now import cheaper drugs. But will Biden get credit?

hotspot

hotspot

Wikipedia

Trump demands the U.S. pay no more for drugs than other countries … again

Covid isolation guidance eased by the CDC

After affirmative action ruling, medical educators look to 'holistic review'

JPM 2024: FogPharma’s CEO unveils ‘contrarian’ plan in oncology

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Pfizer highlights cancer drugs it thinks could reignite investor interest

Wildfire smoke exposes gaps in outdoor worker protections

How to fix the rural physician shortage in the U.S.

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

New menopause drug shows promise in relief for hot flashes

hotspot

Readout LOUD podcast: 2023 in review, and a look at biotech in 2024

Doudna institute plans to 'cure hundreds of diseases' with CRISPR

New England Journal of Medicine addresses racist history, slavery

Caregivers of transplant patients call for more support, training

How I ended up pumping milk in a bathroom stall at JPM 2024

Clinical trials giant ICON acquires HumanFirst

hotspot

leisure time

leisure time

focus